Early Termination of Clinical Trials
This graph shows the total number of publications written about "Early Termination of Clinical Trials" by people in the URMC Research Network by year, and whether "Early Termination of Clinical Trials" was a major or minor topic of these publication.
Below are the most recent publications written about "Early Termination of Clinical Trials" by people in Profiles.
-
Schor NF. What the halted phase III ?-secretase inhibitor trial may (or may not) be telling us. Ann Neurol. 2011 Feb; 69(2):237-9.
-
Yang CC, Burks DA, Propert KJ, Mayer RD, Peters KM, Nickel JC, Payne CK, FitzGerald MP, Hanno PM, Chai TC, Kreder KJ, Lukacz ES, Foster HE, Cen L, Landis JR, Kusek JW, Nyberg LM. Early termination of a trial of mycophenolate mofetil for treatment of interstitial cystitis/painful bladder syndrome: lessons learned. J Urol. 2011 Mar; 185(3):901-6.
-
Rajkumar SV, Jacobus S, Callander NS, Fonseca R, Vesole DH, Williams ME, Abonour R, Siegel DS, Katz M, Greipp PR. Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial. Lancet Oncol. 2010 Jan; 11(1):29-37.
